Filing Flows › U S Physical Therapy (USPH) › Guidance & outlook
U S Physical Therapy (USPH) guidance and outlook
U S Physical Therapy (USPH) reaffirmed its guidance on Nov 6, 2026: EBITDA $102M–$106M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EBITDA | FY2026 | $102M–$106M | reaffirmed |
From the earnings release filed Nov 6, 2026 (8-K on EDGAR).
U S Physical Therapy's latest quarter
U S Physical Therapy, Q3 2026: revenue $223M (+13% year over year), operating margin 11.3%, net earnings $11.0M, operating cash flow $25.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did U S Physical Therapy raise or lower its guidance?
U S Physical Therapy (USPH) reaffirmed its guidance on Nov 6, 2026: EBITDA $102M–$106M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.